Cargando…

Predictors of the effectiveness of an early medication change strategy in patients with major depressive disorder

BACKGROUND: Patients with Major Depressive Disorder (MDD) who are non-improvers after two weeks of antidepressant treatment have a high risk of treatment failure. Recently, we did not find differences in outcomes in non-improvers randomized to an early medication change (EMC) strategy compared to tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dreimüller, Nadine, Wagner, Stefanie, Engel, Alice, Braus, Dieter F., Roll, Sibylle C., Elsner, Stefan, Tadić, André, Lieb, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332626/ https://www.ncbi.nlm.nih.gov/pubmed/30642308 http://dx.doi.org/10.1186/s12888-019-2014-x

Ejemplares similares

Early improvement of executive test performance during antidepressant treatment predicts treatment outcome in patients with Major Depressive Disorder
por: Wagner, Stefanie, et al.
Publicado: (2018)

Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder
por: Tadić, André, et al.
Publicado: (2011)

BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response
por: Lieb, Klaus, et al.
Publicado: (2018)

Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with Major Depressive Disorder - the EMC trial
por: Tadić, André, et al.
Publicado: (2010)

Conflicts of Interest in Medicine. A Systematic Review of Published and Scientifically evaluated Curricula
por: Weißkircher, Janosch, et al.
Publicado: (2017)

Development of a checklist for evaluating psychiatric reports
por: Dreimüller, Nadine, et al.
Publicado: (2019)

Teaching Conflicts of Interest and Shared Decision-Making to Improve Risk Communication: a Randomized Controlled Trial
por: Koch, Cora, et al.
Publicado: (2019)

A coordinate-based ALE functional MRI meta-analysis of brain activation during verbal fluency tasks in healthy control subjects
por: Wagner, Stefanie, et al.
Publicado: (2014)

Development, implementation, and evaluation of a curriculum for medical students on conflicts of interest and communicating risk
por: Deis, Nicole, et al.
Publicado: (2020)

Predictors of recurrence of major depressive disorder
por: Lye, Munn-Sann, et al.
Publicado: (2020)

Predictors of Major Depressive Disorder in Older People
por: Sousa, Susana, et al.
Publicado: (2021)

Rates of Divergent Pharmacogenes in a Psychiatric Cohort of Inpatients with Depression—Arguments for Preemptive Testing
por: Roll, Sibylle Christine, et al.
Publicado: (2022)

Evaluation of Endocrine Parameters as Predictor of Major Depressive Disorder
por: Gupta, Soma, et al.
Publicado: (2017)

MRI predictors of pharmacotherapy response in major depressive disorder
por: Gerlach, Andrew R., et al.
Publicado: (2022)

Predictors of Electroconvulsive Therapy Outcome in Major Depressive Disorder
por: Su, Liang, et al.
Publicado: (2022)

Probiotics as a therapeutic strategy in Major Depressive Disorder
por: Vargas, L.
Publicado: (2022)

Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder
por: Rong, Carola, et al.
Publicado: (2018)

Well-being in major depression and social phobia with and without comorbidity
por: Wersebe, Hanna, et al.
Publicado: (2018)

Brief major depressive episode as an essential predictor of the Bipolar Spectrum Disorder
por: Shabani, Amir, et al.
Publicado: (2009)

Predictors, moderators, and mediators (correlates) of treatment outcome in major depressive disorder
por: Papakostas, George I., et al.
Publicado: (2008)

“GrimAge,” an epigenetic predictor of mortality, is accelerated in major depressive disorder
por: Protsenko, Ekaterina, et al.
Publicado: (2021)

Predictors of Major Depressive Disorder: The Need for Social Approval and Self-Esteem
por: Canlı, Derya, et al.
Publicado: (2021)

Treatment Associated Changes of Functional Connectivity of Midbrain/Brainstem Nuclei in Major Depressive Disorder
por: Wagner, Gerd, et al.
Publicado: (2017)

Treatment strategies to improve and sustain remission in major depressive disorder
por: Madhukar H., Trivedi, et al.
Publicado: (2008)

Quinolinic acid is associated with cognitive deficits in schizophrenia but not major depressive disorder
por: Cathomas, Flurin, et al.
Publicado: (2021)

Pro-Inflammatory Cytokines as Predictors of Antidepressant Effects of Exercise in Major Depressive Disorder
por: Rethorst, Chad D., et al.
Publicado: (2012)

PREDICTORS OF RESPONSE TO ELECTRO-CONVULSIVE THERAPY IN MAJOR DEPRESSION
por: Sivaprakash, B., et al.
Publicado: (2000)

Clinical correlates of augmentation/combination treatment strategies in major depressive disorder
por: Dold, M., et al.
Publicado: (2018)

Major Depressive Disorder Alters Perception of Emotional Body Movements
por: Kaletsch, Morten, et al.
Publicado: (2014)

Association analysis between variants of the interleukin-1β and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression
por: Tadić, André, et al.
Publicado: (2008)

Demographic and psychosocial predictors of major depression and generalised anxiety disorder in Australian university students
por: Farrer, Louise M., et al.
Publicado: (2016)

Predictors of Major Depressive Disorder following Intensive Care of Chronically Critically Ill Patients
por: Wintermann, Gloria-Beatrice, et al.
Publicado: (2018)

Predictors of social anxiety disorder with major depressive episodes among Japanese university students
por: Watanabe, Shinya, et al.
Publicado: (2021)

Age-dependent brain morphometry in Major Depressive disorder
por: Myoraku, Alison, et al.
Publicado: (2021)

Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review
por: Caldiroli, Alice, et al.
Publicado: (2021)

Targeting the ferroptosis crosstalk: novel alternative strategies for the treatment of major depressive disorder
por: Wang, Luyao, et al.
Publicado: (2023)

Neuropsychological functioning in inpatients with major depression or schizophrenia
por: Schaub, Annette, et al.
Publicado: (2013)

Predictors of the Onset of Manic Symptoms and a (Hypo)Manic Episode in Patients with Major Depressive Disorder
por: Boschloo, Lynn, et al.
Publicado: (2014)

Early Symptom Improvement as a Predictor of Response to Extended Release Quetiapine in Major Depressive Disorder
por: McIntyre, Roger S., et al.
Publicado: (2015)

Gender differential in social and economic predictors of incident major depressive disorder in the Ibadan Study of Ageing
por: Ojagbemi, Akin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sbdf5uiabv8cojvstks3c8qhva